15.悪性リンパ腫の標準的治療
Saved in:
| Published in | 日本内科学会雑誌 Vol. 91; no. Supplement-Sep; pp. 292 - 297 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Japanese |
| Published |
一般社団法人 日本内科学会
2002
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 0021-5384 1883-2083 |
| DOI | 10.2169/naika.91.Supplement-Sep_292 |
Cover
| Author | 堀田, 知光 |
|---|---|
| Author_xml | – sequence: 1 fullname: 堀田, 知光 organization: 東海大学内科 |
| BookMark | eNplkM1Kw0AUhQepYK19CheuEufOTZqZpRT_oOCiuh5uMhNNbWNI6sKdtvUB3Aj1BZQKLnSnjxNIfQzrD7pwdeDAOZzvrLJaepZaxtaBuwJaajOl5JRcBW73PMv6dmDTodO1mRZKLLE6SImO4BJrrM65AMdH6a2wZlEkIfew5UtAr842wHer0ay6vC_Hs3L8Uo5v3q8fy6un6mFavd7O7ybV89t8OlpjyzH1C9v80QY72tk-bO85nYPd_fZWx-kJ3-cOCmME2VhFRJLCiJSMSQbS5yYKA6HAeIsxBiNCIFCI1hgOcWAgFhDGhA2mv3t7xZCOrc7yZED5haZ8mER9q7-gQQFqBfoPXH-C_3cWV_wmoxPKdY_wA1L9bik |
| ContentType | Journal Article |
| Copyright | (社)日本内科学会 |
| Copyright_xml | – notice: (社)日本内科学会 |
| DOI | 10.2169/naika.91.Supplement-Sep_292 |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1883-2083 |
| EndPage | 297 |
| ExternalDocumentID | article_naika1913_91_Supplement_Sep_91_Supplement_Sep_292_article_char_ja |
| GroupedDBID | ALMA_UNASSIGNED_HOLDINGS DIK F5P JSF OK1 RJT ZXP |
| ID | FETCH-LOGICAL-j2550-32dd2aef9caa8abca98fa87850dcb7291d4002d3ca31a1933edd01f7d1f21bfa3 |
| ISSN | 0021-5384 |
| IngestDate | Wed Sep 03 06:30:37 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | Supplement-Sep |
| Language | Japanese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-j2550-32dd2aef9caa8abca98fa87850dcb7291d4002d3ca31a1933edd01f7d1f21bfa3 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/naika1913/91/Supplement-Sep/91_Supplement-Sep_292/_article/-char/ja |
| PageCount | 6 |
| ParticipantIDs | jstage_primary_article_naika1913_91_Supplement_Sep_91_Supplement_Sep_292_article_char_ja |
| PublicationCentury | 2000 |
| PublicationDate | 20020000 |
| PublicationDateYYYYMMDD | 2002-01-01 |
| PublicationDate_xml | – year: 2002 text: 20020000 |
| PublicationDecade | 2000 |
| PublicationTitle | 日本内科学会雑誌 |
| PublicationTitleAlternate | 日内会誌 |
| PublicationYear | 2002 |
| Publisher | 一般社団法人 日本内科学会 |
| Publisher_xml | – name: 一般社団法人 日本内科学会 |
| References | 3) Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on advanced Hodgkin's Disease. N Engl J Med 339: 1056-1506, 1998. 10) Shipp MA, et al: A predictive model for aggressive NHL: The International Non-Hodgkin's Lymphoma Prognostic Factor Project. N Engl J Med 329: 987-997, 1993. 7) Canellos GP, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 19: 1478-1484, 1990. 1) がんの統計編集委員会:がんの統計.柿添忠生編財団法人がん研究振興財団, 2001. 8) Takenaka T, et al: Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a muticenter phase II study (JCOG 8905). Jpn J Clin Oncol 30: 146-152, 2000. 12) Czuczman MS, et al: Treatment of patients with lowgrade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17: 268-276, 1999. 17) Philip T, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333: 1540-1545, 1995. 2) Lymphoma Study Group of Japanese Pathologists: The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Intern 50: 696-702, 2000. 19) Magrath I, et at: Adults and children with small noncleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14: 925-934, 1996. 5) van Leeuwen FE, et al: Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 12: 312-325, 1994. 9) Ogura M, et al: Phase II study of ABVd therapy for advanced stage Hodgkin's disease (Hd) in Japan: Japan Clinical Oncology Group (JCOG) study (JCOG9305) Proc ASCO 2001: 2673a. 18) Reiter A, et al: Intensive ALL-type chemotherapy without local radiotherapy provides a 90%event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95: 416-421, 2000. 14) Miller TP, et al: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-intermediate grade non-Hodgkin's lymphoma. N Engl J Med 339: 21-26, 1998. 21) Yamada Y, et al: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical oncology Group study 9303. Br J Haematol 113: 375-382, 2001. 15) Fisher RI, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328: 1002-1006, 1993. 16) Coiffier B, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235-242, 2002. 11) Young RC, et al: The treatment of indolent lymphomas: watchful waiting versus aggressive combined modality treatment. Semin Hematol 25: 11-18, 1988. 6) Bhatia S, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334: 745-751, 1996. 20) Lee EJ, et al: Brief-durtion high-intensity chermotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocitic leukemia: results of Cancer and Leukemia Group B study 9251. J Clin oncol 19: 4014-4022, 2001. 4) Specht L, et al: Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3888 patients. J Clin Oncol 16: 830-843, 1998. 13) Vose JM, et al: Phase II study of rituximab in combination with CHOP chemotharpy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. J Clin Oncol 19: 389-397, 2001. |
| References_xml | – reference: 6) Bhatia S, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334: 745-751, 1996. – reference: 1) がんの統計編集委員会:がんの統計.柿添忠生編財団法人がん研究振興財団, 2001. – reference: 3) Hasenclever D, Diehl V: A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on advanced Hodgkin's Disease. N Engl J Med 339: 1056-1506, 1998. – reference: 15) Fisher RI, et al: Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 328: 1002-1006, 1993. – reference: 12) Czuczman MS, et al: Treatment of patients with lowgrade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy. J Clin Oncol 17: 268-276, 1999. – reference: 9) Ogura M, et al: Phase II study of ABVd therapy for advanced stage Hodgkin's disease (Hd) in Japan: Japan Clinical Oncology Group (JCOG) study (JCOG9305) Proc ASCO 2001: 2673a. – reference: 13) Vose JM, et al: Phase II study of rituximab in combination with CHOP chemotharpy in patients with previously untreated, aggressive non-Hodgkin's lymphoma. J Clin Oncol 19: 389-397, 2001. – reference: 11) Young RC, et al: The treatment of indolent lymphomas: watchful waiting versus aggressive combined modality treatment. Semin Hematol 25: 11-18, 1988. – reference: 17) Philip T, et al: Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 333: 1540-1545, 1995. – reference: 2) Lymphoma Study Group of Japanese Pathologists: The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Intern 50: 696-702, 2000. – reference: 8) Takenaka T, et al: Alternating combination chemotherapy C-MOPP (cyclophosphamide, vincristine, procarbazine, prednisone) and ABVd (adriamycin bleomycin, vinblastine, dacarbazine) in clinical stage II-IV Hodgkin's disease: a muticenter phase II study (JCOG 8905). Jpn J Clin Oncol 30: 146-152, 2000. – reference: 14) Miller TP, et al: Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate-and high-intermediate grade non-Hodgkin's lymphoma. N Engl J Med 339: 21-26, 1998. – reference: 4) Specht L, et al: Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease: a meta-analysis of 23 randomized trials involving 3888 patients. J Clin Oncol 16: 830-843, 1998. – reference: 19) Magrath I, et at: Adults and children with small noncleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14: 925-934, 1996. – reference: 16) Coiffier B, et al: CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346: 235-242, 2002. – reference: 7) Canellos GP, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 19: 1478-1484, 1990. – reference: 10) Shipp MA, et al: A predictive model for aggressive NHL: The International Non-Hodgkin's Lymphoma Prognostic Factor Project. N Engl J Med 329: 987-997, 1993. – reference: 20) Lee EJ, et al: Brief-durtion high-intensity chermotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocitic leukemia: results of Cancer and Leukemia Group B study 9251. J Clin oncol 19: 4014-4022, 2001. – reference: 21) Yamada Y, et al: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical oncology Group study 9303. Br J Haematol 113: 375-382, 2001. – reference: 18) Reiter A, et al: Intensive ALL-type chemotherapy without local radiotherapy provides a 90%event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 95: 416-421, 2000. – reference: 5) van Leeuwen FE, et al: Second cancer risk following Hodgkin's disease: a 20-year follow-up study. J Clin Oncol 12: 312-325, 1994. |
| SSID | ssib043658134 ssj0066765 ssib002821954 ssib005879745 ssib007485360 ssib058493862 ssib000940260 ssib002484664 |
| Score | 1.5815054 |
| SourceID | jstage |
| SourceType | Publisher |
| StartPage | 292 |
| SubjectTerms | ホジキンリンパ腫 標準的治療 臨床試験 非ホジキンリンパ腫 |
| Title | 15.悪性リンパ腫の標準的治療 |
| URI | https://www.jstage.jst.go.jp/article/naika1913/91/Supplement-Sep/91_Supplement-Sep_292/_article/-char/ja |
| Volume | 91 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | 日本内科学会雑誌, 2002/09/20, Vol.91(Supplement-Sep), pp.292-297 |
| journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1883-2083 dateEnd: 99991231 omitProxy: true ssIdentifier: ssib007485360 issn: 0021-5384 databaseCode: KQ8 dateStart: 19130101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1883-2083 dateEnd: 20061231 omitProxy: true ssIdentifier: ssj0066765 issn: 0021-5384 databaseCode: DIK dateStart: 19130101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1Ni1MxMKwrLF7ET_xmQQcP8mqTvI_kmFffsirrxV3o7fE-Dz10F6kXT7rVH-BFWP-AsoIHvenPKXT9GU4mr-2riuiiUMJ0mplJMmkyE5IZxm7hFqt5oaUX6lJ6foi6yEPhe37AZaH9MgopxMbWo3Bzx3_QD_orJ-L265JR3ime_fJdyXG0ijjUq30l-xeanTNFBMKoXyxRw1j-kY550IEkBCXAGAK6YCJIJChJGAJi2QCaQ6JABWBiwnAwiaUyCrS2QGxAh5BEoA0onzAC4pgwGlz2npkha3_VEZiAgB6YHiQBqNDyx_rYDCsOZd0Dgzx9iHuWbaJBx01LsIVqfkZLdbu2B1YaVu9a5dOXDZISWM4uD9D8lGLhzZIEReRYKmoOtgKRiSVFmUZSh3AYAqps8HPneL1or_SCe7iYu8OKyi3uSkmcPy5xzmz1d7nCmllOmVTpWNZ7XO2113WXsK8xEYS7Uvzj7iN4aIO3Du3br47mnWVu6ZzHUnjvZvKkRIXOs0w1TxeUqaX8GYO80hmlfZ6XDtBHOCkitLasY3D_YcuE9m3YuJZJppYyCqDLzdshAQMV6XYGhMhHg25B70s0WfkipCDar1qqcB6yzV6ZdllDmvFfYzebobn7m4FB-2-A3tDsJiUZd9tn2OnGK1s3rq9n2cogO8fWtpp7J-fZbfynTfcPp8_fTcaHk_Hnyfj1t1cfJi8-Tt8fTL-8OXr7cvrp69HB_gW2s5Fs9za9JsWIN0BfGi0QUZYiq2pdZJnK8iLTqs5UpIJuWeTod_IS9zhRyiKTHLUjZVWWXV5HJa8Fz-tMXmSrw91hdYmtl7wQeaUqhQ66DfKZZbnkQZ13K63DotCXWd91Md1zcWTSf6b6K_-P9VV2ivIf0aHjNbY6evK0uo5m-Ci_QfPsOx8gu9c |
| linkProvider | Flying Publisher |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=15.%E6%82%AA%E6%80%A7%E3%83%AA%E3%83%B3%E3%83%91%E8%85%AB%E3%81%AE%E6%A8%99%E6%BA%96%E7%9A%84%E6%B2%BB%E7%99%82&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E5%A0%80%E7%94%B0%2C+%E7%9F%A5%E5%85%89&rft.date=2002&rft.pub=%E4%B8%80%E8%88%AC%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%86%85%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5384&rft.eissn=1883-2083&rft.volume=91&rft.issue=Supplement-Sep&rft.spage=292&rft.epage=297&rft_id=info:doi/10.2169%2Fnaika.91.Supplement-Sep_292&rft.externalDocID=article_naika1913_91_Supplement_Sep_91_Supplement_Sep_292_article_char_ja |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5384&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5384&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5384&client=summon |